Nom du produit:2,6-Dichloroquinoline-3-carbaldehyde
IUPAC Name:2,6-dichloroquinoline-3-carbaldehyde
- CAS：73568-41-9
- Formule moléculaire：C10H5Cl2NO
- Pureté：95%
- Numéro de catalogue：CM145849
- Poids moléculaire：226.06
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:73568-41-9
- Formule moléculaire:C10H5Cl2NO
- Point de fusion:-
- Code SMILES:O=CC1=CC2=CC(Cl)=CC=C2N=C1Cl
- Densité:
- Numéro de catalogue:CM145849
- Poids moléculaire:226.06
- Point d'ébullition:357.5°C at 760 mmHg
- N° Mdl:MFCD06202347
- Stockage:Store at 2-8°C.
Category Infos
- Quinolines
- Quinolines are an important class of biologically active heterocyclic compounds, and their derivatives usually exhibit a variety of biological activities. They can be used as antimalarial drugs and in the preparation of other antimalarial drugs. Other important activities of quinoline derivatives include inhibitory activity against EGFR-TK and antipsychotic activity. Futhermore, quinoline scaffolds are present in various drug molecules, including the antimalarial drugs aablaquine, chloroquine, mefloquine and primaquine, and the antibacterial agents gatifloxacin, levofloxacin, and moxifloxacin.
- Quinoline Price
- if you have any question on quinoline price, we will give the professional answers to your short questions.
Column Infos
- Olutasidenib
- Rigel announces publication of data on REZLIDHIA(Olutasidenib) in post-venetoclax patients with mutant IDH1 AML in Leukemia & Lymphoma.
REZLIDHIA (Olutasidenib), a potent, selective, oral, small-molecule inhibitor of mutant isocitrate dehydrogenase-1 (mIDH1), in patients with mIDH1 acute myeloid leukemia (AML) who were relapsed/refractory (R/R) to prior venetoclax-based regimens.
Recherche 
+86 21 5895 0110 
